PANBELA THERAPEUTICS, INC.
712 Vista Blvd, #305
Waconia, MN 55387
May 10, 2021
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Re: | Panbela Therapeutics, Inc. |
Registration Statement on Form S-3 (File No. 333-255751)
Request for Acceleration of Effectiveness
Ladies and Gentlemen:
Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, Panbela Therapeutics, Inc. (the “Registrant”) hereby requests that the above-referenced Registration Statement be declared effective by the Securities and Exchange Commission on May 11, 2021, at 4:00 p.m., Eastern Time, or as soon thereafter as practicable.
The Registrant hereby authorizes Joshua Colburn, of Faegre Drinker Biddle & Reath LLP, to orally modify or withdraw this request for acceleration.
[SIGNATURE PAGE FOLLOWS]
Very truly yours, | ||||
PANBELA THERAPEUTICS, INC. | ||||
By: | /s/ Jennifer K. Simpson | |||
Name: | Jennifer K. Simpson | |||
Title: | President and Chief Executive Officer |
[SIGNATURE PAGE TO REQUEST FOR ACCELERATION]